CLBS Quote, Trading Chart, Caladrius Biosciences Inc.
home / stock / clbs / clbs quote
$1.82 Last:
-4.21% Change Percent:
$1.88 Open:
$1.82 Previous Close:
$1.93 High:
$1.52 Low:
7,546,454 Volume:
03/04/2021 04:55:23 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-04 | 1.88 | 1.82 | 1.93 | 1.52 | 7,546,454 |
| 2021-03-03 | 1.87 | 1.9 | 2.15 | 1.79 | 10,457,863 |
| 2021-03-02 | 1.92 | 1.86 | 2.02 | 1.86 | 1,984,664 |
| 2021-03-01 | 1.86 | 1.92 | 1.95 | 1.81 | 2,737,994 |
| 2021-02-26 | 1.84 | 1.78 | 1.93 | 1.74 | 4,337,210 |
| 2021-02-25 | 2.08 | 1.91 | 2.1 | 1.91 | 3,873,422 |
| 2021-02-24 | 1.9194 | 2.12 | 2.18 | 1.91 | 5,801,119 |
| 2021-02-23 | 2.02 | 1.87 | 2.07 | 1.56 | 9,720,697 |
| 2021-02-22 | 2.31 | 2.23 | 2.3593 | 2.17 | 7,383,372 |
| 2021-02-19 | 2.25 | 2.29 | 2.33 | 2.2 | 7,239,156 |
| 2021-02-18 | 2.39 | 2.19 | 2.49 | 2.17 | 11,090,570 |
| 2021-02-17 | 2.49 | 2.37 | 2.5 | 2.25 | 9,966,262 |
| 2021-02-16 | 2.55 | 2.44 | 2.65 | 2.43 | 20,953,448 |
| 2021-02-15 | 2.1 | 2.33 | 2.4 | 2.06 | 40,534,921 |
| 2021-02-12 | 2.1 | 2.33 | 2.4 | 2.06 | 39,606,366 |
| 2021-02-11 | 2.38 | 2.73 | 3.05 | 2.22 | 16,655,262 |
| 2021-02-10 | 2.317 | 2.34 | 2.45 | 2.14 | 6,405,502 |
| 2021-02-09 | 2.44 | 2.3 | 2.46 | 2.27 | 7,774,078 |
| 2021-02-08 | 2.27 | 2.23 | 2.32 | 2.09 | 6,384,396 |
| 2021-02-05 | 2.4 | 2.32 | 2.4 | 2.21 | 909,818 |
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
Caladrius Biosciences Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
BASKING RIDGE, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, anno...
-
Company demonstrates resilience despite COVID-19 challenges: Financial situation secure and development programs progressing Conference call begins today at 4:30 p.m. (ET) BASKING RIDGE, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (&#...
-
BASKING RIDGE, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today ...